Skye Bioscience, Inc. Short-term Debt
Skye Bioscience, Inc. (SKYE) had Short-term Debt of $71.10 thousand as of 2020-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Short-Term Debt
us-gaap:ShortTermBorrowings · last filed 2020-11-06
- 2020-09-30: Short-term Debt $71.10K.
- 2020-06-30: Short-term Debt $51.65K.
| Period end | Short-term Debt |
|---|---|
| 2020-09-30 | $71.10K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $51.65K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |